Ankit Mahadevia Spero Therapeutics, Inc. (SPRO) insider trading activity

Ankit Mahadevia is of Spero Therapeutics, Inc.. Currently has a direct ownership of 759,085 shares of SPRO, which is worth approximately $880,538. The most recent transaction as insider was on Aug 27, 2024, when has been sold 5,912 shares (Common Stock) at a price of $1.35 per share, resulting in proceeds of $7,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 759K

0.77% 3M change

6.15% 12M change

Total Value Held $880,538

Ankit Mahadevia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 27 2024	SELL Open market or private sale	$7,981 $1.35 p/Share	5,912 Reduced 0.77%	759,085 Common Stock
May 29 2024	BUY Grant, award, or other acquisition	-	20,000 Added 2.55%	764,997 Common Stock
Feb 02 2024	SELL Open market or private sale	$87,399 $1.37 p/Share	63,795 Reduced 7.89%	744,997 Common Stock
Oct 05 2023	BUY Grant, award, or other acquisition	-	20,000 Added 2.41%	808,792 Common Stock
Aug 28 2023	SELL Open market or private sale	$11,390 $1.26 p/Share	9,040 Reduced 1.13%	788,792 Common Stock
Feb 03 2023	SELL Open market or private sale	$22,237 $1.81 p/Share	12,286 Reduced 1.52%	797,832 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	531,914 Added 39.63%	810,118 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	134,168 Added 32.54%	278,204 Common Stock
Dec 27 2021	SELL Open market or private sale	$116,640 $14.58 p/Share	8,000 Reduced 5.26%	144,036 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$47,200 $5.9 p/Share	8,000 Added 5.0%	152,036 Common Stock
Aug 26 2021	BUY Grant, award, or other acquisition	-	78,219 Added 35.19%	144,036 Common Stock
Nov 04 2020	SELL Open market or private sale	$106,349 $14.43 p/Share	7,370 Reduced 10.07%	65,817 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$43,483 $5.9 p/Share	7,370 Added 9.15%	73,187 Common Stock
Nov 03 2020	SELL Open market or private sale	$30,495 $14.27 p/Share	2,137 Reduced 3.14%	65,817 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$12,608 $5.9 p/Share	2,137 Added 3.05%	67,954 Common Stock
Oct 23 2020	SELL Open market or private sale	$285 $14.25 p/Share	20 Reduced 0.03%	65,817 Common Stock
Oct 23 2020	BUY Exercise of conversion of derivative security	$118 $5.9 p/Share	20 Added 0.03%	65,837 Common Stock
Oct 14 2020	SELL Open market or private sale	$1,496 $14.25 p/Share	105 Reduced 0.16%	65,817 Common Stock
Oct 14 2020	BUY Exercise of conversion of derivative security	$620 $5.9 p/Share	105 Added 0.16%	65,922 Common Stock
Oct 13 2020	SELL Open market or private sale	$205,161 $14.28 p/Share	14,367 Reduced 17.92%	65,817 Common Stock
Oct 13 2020	BUY Exercise of conversion of derivative security	$84,765 $5.9 p/Share	14,367 Added 15.19%	80,184 Common Stock

Ankit Mahadevia

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Value

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Spero Therapeutics, Inc.

Track Activities on SPRO

Account